About Wheeler Bio
Wheeler Bio is a company based in Oklahoma City (United States) founded in 2020 by Jesse McCool.. Wheeler Bio has raised $103.15 million across 5 funding rounds from investors including Charles River Laboratories, Alloy Therapeutics and Mitsubishi Corporation. Wheeler Bio offers products and services including Modular CMC Services, Cell Line Development, and Process Development. Wheeler Bio operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
- Headquarter Oklahoma City, United States
- Founders Jesse McCool
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$103.15 M (USD)
in 5 rounds
-
Latest Funding Round
$35 M (USD), Series A
Mar 04, 2025
-
Investors
Charles River Laboratories
& 14 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Wheeler Bio
Wheeler Bio offers a comprehensive portfolio of products and services, including Modular CMC Services, Cell Line Development, and Process Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Accelerates biologics from discovery to clinical supply with efficient processes.
Creates stable cell lines for protein expression and preclinical testing.
Optimizes manufacturing processes for biologics production and characterization.
Unlock access to complete
Funding Insights of Wheeler Bio
Wheeler Bio has successfully raised a total of $103.15M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $35 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $35.0M
-
First Round
First Round
(11 Jan 2022)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series A - Wheeler Bio | Valuation | Alloy Therapeutics , Echo | |
| Apr, 2023 | Amount | Series A - Wheeler Bio | Valuation | Charles River Laboratories , Echo Investment | |
| Jan, 2023 | Amount | Series A - Wheeler Bio | Valuation | Boyd Street Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Wheeler Bio
Wheeler Bio has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Charles River Laboratories, Alloy Therapeutics and Mitsubishi Corporation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Echo Investment Capital is engaged in multi-strategy investment management.
|
Founded Year | Domain | Location | |
|
Venture capital investments are focused on FoodTech and AgTech sectors.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on tech companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Wheeler Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Wheeler Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wheeler Bio Comparisons
Competitors of Wheeler Bio
Wheeler Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| domain | founded_year | HQ Location |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
|
| domain | founded_year | HQ Location |
APIs and finished dosage forms are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wheeler Bio
Frequently Asked Questions about Wheeler Bio
When was Wheeler Bio founded?
Wheeler Bio was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Wheeler Bio located?
Wheeler Bio is headquartered in Oklahoma City, United States. It is registered at Oklahoma City, Oklahoma, United States.
Who is the current CEO of Wheeler Bio?
Jesse McCool is the current CEO of Wheeler Bio. They have also founded this company.
Is Wheeler Bio a funded company?
Wheeler Bio is a funded company, having raised a total of $103.15M across 5 funding rounds to date.
What does Wheeler Bio do?
Wheeler Bio was founded in 2020 and is headquartered in Oklahoma City, United States. Services in drug research and analytical development are offered by the company across various therapeutic areas within the biotechnology sector. Operations emphasize support for pharmaceutical innovation, including process optimization and quality assurance. Leadership is provided by co-founder and CEO Jesse McCool, with a focus on reliable, data-driven solutions for clients in the life sciences industry.
Who are the top competitors of Wheeler Bio?
Wheeler Bio's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
What products or services does Wheeler Bio offer?
Wheeler Bio offers Modular CMC Services, Cell Line Development, and Process Development.
Who are Wheeler Bio's investors?
Wheeler Bio has 15 investors. Key investors include Charles River Laboratories, Alloy Therapeutics, Mitsubishi Corporation, Echo Investment, and Atum.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.